Nexkem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.50 M
as on 23-10-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.52 Cr
as on 23-10-2024
- Revenue 25.72%
(FY 2023)
- Profit 8.61%
(FY 2023)
- Ebitda 766.26%
(FY 2023)
- Net Worth 35.94%
(FY 2023)
- Total Assets 74.00%
(FY 2023)
About Nexkem Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.52 Cr.
Ram Chhaba and Sunita Chhaba serve as directors at the Company.
- CIN/LLPIN
U24299RJ2016PTC056214
- Company No.
056214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nexkem Pharmaceuticals Private Limited offer?
Nexkem Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug, Common Disease Medicines, Pharmaceutical Medicine, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Dietary Supplements, Cardiovascular Drugs & Medication, Antianginal Drugs, Pharma & Bioanalytical Services.
Who are the key members and board of directors at Nexkem Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Chhaba  | Director | 24-Aug-2021 | Current |
| Sunita Chhaba | Director | 17-Oct-2016 | Current |
Financial Performance of Nexkem Pharmaceuticals.
Nexkem Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.72% increase. The company also saw a slight improvement in profitability, with a 8.61% increase in profit. The company's net worth Soared by an impressive increase of 35.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexkem Pharmaceuticals?
Unlock access to Nexkem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Sep 2024 | ₹2.74 Cr | Open |
Others Creation Date: 20 Feb 2024 | ₹2.27 Cr | Open |
Others Creation Date: 10 Feb 2024 | ₹2.43 M | Open |
How Many Employees Work at Nexkem Pharmaceuticals?
Unlock and access historical data on people associated with Nexkem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexkem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexkem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
